Back to Search Start Over

Formulating biopharmaceuticals using three-dimensional printing.

Authors :
Chan AKC
Ranjitham Gopalakrishnan N
Traore YL
Ho EA
Source :
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques [J Pharm Pharm Sci] 2024 Mar 15; Vol. 27, pp. 12797. Date of Electronic Publication: 2024 Mar 15 (Print Publication: 2024).
Publication Year :
2024

Abstract

Additive manufacturing, commonly referred to as three-dimensional (3D) printing, has the potential to initiate a paradigm shift in the field of medicine and drug delivery. Ever since the advent of the first-ever United States Food and Drug Administration (US FDA)-approved 3D printed tablet, there has been an increased interest in the application of this technology in drug delivery and biomedical applications. 3D printing brings us one step closer to personalized medicine, hence rendering the "one size fits all" concept in drug dosing obsolete. In this review article, we focus on the recent developments in the field of modified drug delivery systems in which various types of additive manufacturing technologies are applied.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2024 Chan, Ranjitham Gopalakrishnan, Traore and Ho.)

Details

Language :
English
ISSN :
1482-1826
Volume :
27
Database :
MEDLINE
Journal :
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques
Publication Type :
Academic Journal
Accession number :
38558867
Full Text :
https://doi.org/10.3389/jpps.2024.12797